Skip to main content
Fig. 8 | Cancer Cell International

Fig. 8

From: Exosome-derived circKIF20B suppresses gefitinib resistance and cell proliferation in non-small cell lung cancer

Fig. 8

CircKIF20B acts as a tumor suppressor in NSCLC in vivo. A and B Images of the xenograft tumors from the circKIF20B-OE group, the GV689-NC, served as the control. C and D Growth curves and weight analysis of tumors from the circKIF20B-OE and GV689-NC groups. E The expression of circKIF20B, miR-615-3p, and MEF2A in xenograft tumors from the circKIF20B-OE and GV689-NC groups. F The protein expression of MEF2A in the circKIF20B-OE groups in vivo. G IHC and HE is staining of the tumor sections in the circKIF20B-OE group with MEF2A and Ki67 antibodies

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us